Cargando…
Correction: Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619721/ https://www.ncbi.nlm.nih.gov/pubmed/26495850 http://dx.doi.org/10.1371/journal.pone.0140921 |
Ejemplares similares
-
Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
por: Romero-Lorca, Alicia, et al.
Publicado: (2015) -
Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
por: Sutliff, Aimee K., et al.
Publicado: (2019) -
Implication of Human UGT2B7, 2B15, and 2B17 in 19-Norandrosterone Metabolism
por: Strahm, Emmanuel, et al.
Publicado: (2013) -
Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children
por: Du, Zhongliang, et al.
Publicado: (2016) -
Role of the UGT2B17 deletion in exemestane pharmacogenetics
por: Luo, Shaman, et al.
Publicado: (2017)